Treated Retinopathy of Prematurity

  • Research type

    Research Study

  • Full title

    UK Surveillance of Treated Retinopathy of Prematurity

  • IRAS ID

    128249

  • Contact name

    Gill Adams

  • Contact email

    gill.adams@moorfields.nhs.uk

  • Sponsor organisation

    Moorfields Eye Hospital NHS Foundation Trust

  • Research summary

    Currently there is little recent data on regional variations in treatment methods, neonatal units that provide retinopathy (ROP) treatment, facilities for treatment available at each unit including anaesthetic support for such preterm babies, facilities to transfer babies to units that offer treatment etc. While some parts of the UK have established neonatal networks and agreements among units for ROP treatment, in other parts, such arrangements are ill-defined. The number of babies needing ROP treatment may be higher since the introduction of revised guidelines in 2008 as earlier treatment has been shown to be beneficial. Collecting epidemiological data through the British Ophthalmic Surveillance Unit (BOSU) on the incidence of treatable ROP, the treatment methods used and facilities for treatment will provide the foundation for effective planning or resources and manpower to deal with the additional demand.

  • REC name

    North of Scotland Research Ethics Committee 2

  • REC reference

    13/NS/0059

  • Date of REC Opinion

    11 Jun 2013

  • REC opinion

    Further Information Favourable Opinion